Eli Lilly has announced that its Zepbound (tirzepatide) was superior to Novo Nordisk’s Wegovy (semaglutide) across all weight ...

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...